Roth Capital Resumes Coverage on Halozyme Therapeutics (HALO) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. SPY
2. EYPT
3. NVDA
4. ARGX
5. AWK
6. TSLA
7. USO
8. GNK
9. PLUR
10. RKLB

August 11, 2011 10:22 AM EDT
Get Alerts HALO Hot Sheet
Price: $103.00 --0%

Rating Summary:
    15 Buy, 5 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 4 | Down: 8 | New: 8
Join SI Premium – FREE
Roth Capital resumes coverage on Halozyme Therapeutics (NASDAQ: HALO) with a Buy. PT $14.00.

For more ratings news on Halozyme Therapeutics click here and for the rating history of Halozyme Therapeutics click here.

Shares of Halozyme Therapeutics closed at $6.02 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Roth Capital